The Korean government announced ‘the Bio-health Industry Innovation Strategy’, a large-scale investment plan for the Bio-health industry such as pharmaceuticals, Bio-big data, and medical devices in an effort to nurture what it sees as a future growth engine. It plans to dial up the amount of annual R&D investment in the Bio-health industry sector to more than 4 trillion won by 2025 from 2.6 trillion in 2017 to strengthen their competitiveness and technological capabilities. Moreover, the growth rate for the Bio-health industry sector in 2030 is forecast to be 4.0% annually. Therefore, we believe that the Bio-health industry has high future growth potential. Recently, as the demand for personalized medicine development in patients and new medical technologies increases, it is time to cultivate specialists in research and development of next-generation Biomedicine necessary for Pharmaceutical companies and Bio Venture.
'Research & Education Group for Innovative Bio-health Industry' in Soonchunhyang University fosters excellent innovative researchers who will lead the development of next-generation Biomedicine. Our group aims to induce the convergence of multidisciplinary between Biology, Biomedicine, and Bio-big Data based on the reform of innovative education program & the development of research competence program and to cultivate leading researchers in the field of Biomedical industry.
Prof. Sung-Hwan Yun
Director. BK21 Four Project
| Vision | A Great Leap Forward for the Advanced Expert Training Institute for the Development of Biomedicine in the Chungcheong Region |
|---|---|
| Goal |
|